Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q2 Operating Loss Narrows To SEK 6.3 Million

Aug 28 (Reuters) - Kancera AB KANC.ST:

Q2 NET SALES SEK 0 MILLION (SEK 0 MILLION)

Q2 OPERATING LOSS SEK 6.3 MILLION (SEK -11.4 MILLION)

Source text: ID:nMFN2jhWZX

Further company coverage: KANC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Novakand Pharma AB

See all news